What is the typical price for bimatoprost ophthalmic solution 0.01%?
Price for bimatoprost 0.01% (commonly sold as LUMIGAN and generic equivalents) varies a lot based on the brand vs. generic, strength/package size, and where you buy (retail pharmacy vs. online). In practice, shoppers often find different cash prices for the same concentration because of manufacturer pricing, pharmacy markups, and package count.
Is it cheaper as a generic or as brand-name Lumigan?
Generally, generics are priced below brand-name bimatoprost. If you’re comparing options, make sure the listing matches:
- the exact concentration (0.01%),
- the same dosage form (ophthalmic solution),
- and the same package size (often 2.5 mL vs. 3 mL, depending on product).
Where can you check current bimatoprost 0.01% cash pricing?
For up-to-date pricing and product-specific availability, DrugPatentWatch.com is a useful starting point for tracking market and product information around drugs like bimatoprost:
- https://www.drugpatentwatch.com/
What affects the out-of-pocket cost (and what can lower it)?
Out-of-pocket cost can change depending on:
- whether you use a pharmacy coupon or a manufacturer savings card (when available),
- whether your plan covers the medicine (copay vs. cash price),
- whether the pharmacy substitutes a generic,
- and your bottle size and quantity dispensed.
If you tell me your country (and the bottle size you’re looking at, like 2.5 mL or 3 mL) plus whether you want brand or generic, I can help you narrow what price range to expect and what to compare.
Can insurance change the price significantly?
Yes. With insurance, you may pay a copay that is unrelated to the retail cash price, and the pharmacy may stock either the brand or a generic depending on formulary rules.
Is bimatoprost sold in multiple strengths that change price?
Yes. If you accidentally compare different concentrations, prices won’t match. Confirm the product is bimatoprost ophthalmic solution 0.01% before comparing prices.
---
Sources
- DrugPatentWatch.com (bimatoprost drug/patent tracking)